Where does Guangdong Newdermo Biotech Co., Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Guangdong Newdermo Biotech Co., Ltd ranks #40,555 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Guangdong Newdermo Biotech Co., Ltd hold?

Guangdong Newdermo Biotech Co., Ltd holds 6 US utility patents granted between 2022 and 2023, spanning 6 technology areas.

What is Guangdong Newdermo Biotech Co., Ltd's Innovation Score?

Guangdong Newdermo Biotech Co., Ltd has an Innovation Score of 36.9 out of 100 (top 45% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Guangdong Newdermo Biotech Co., Ltd's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Guangdong Newdermo Biotech Co., Ltd.

What does claim depth mean for Guangdong Newdermo Biotech Co., Ltd's patents?

Guangdong Newdermo Biotech Co., Ltd's patents average 2.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Guangdong Newdermo Biotech Co., Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Guangdong Newdermo Biotech Co., Ltd

Q: What technology areas does Guangdong Newdermo Biotech Co., Ltd focus on?

Guangdong Newdermo Biotech Co., Ltd's top technology area is D01F (Chemical Features IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR RIBBONS; Apparatus Specially Adapted FOR THE Manufacture OF Carbon Filaments) with 1 patents, ranking #218 of 354 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2022–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: D01F (Chemical Features IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR RIBBONS; Apparatus Specially Adapted FOR THE Manufacture OF Carbon Filaments).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Guangdong ranks #40,555 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#40,555
of 49,997 US assignees by volume: Top 45%
by Innovation Score (36.9/100): 2.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R40555 · Foreign Corporation #40,555 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #40,555/49,997
PHOTO-FINISH Guangdong Fenghua…
CPC-NARROW D01F · 6 areas
INNOV-THIN 36.9/100
CLAIMS-SPARSE 2.5 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2023 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Guangdong Fenghua Advanced Technology Holding Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Guangdong’s 36.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (18%) Velocity 20.0 pts (54%) Breadth 8.7 pts (24%) Claim depth 1.5 pts (4%)

Qualcomm Incorporated · highest

85
Guangdong Newdermo… · this assignee

37
3D Lighting… · lowest

7

What this shows Guangdong's Innovation Score is 36.9/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Guangdong?

Each dot is one of Guangdong’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Guangdong’s own 2.5 claims/patent is at or below the 12.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Guangdong vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Guangdong's grants concentrate

Guangdong Newdermo Biotech Co., Ltd is a focused PatentsView assignee: 6 CPC subclasses with 16.7% of grants classified under D01F (Chemical Features IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR RIBBONS; Apparatus Specially Adapted FOR THE Manufacture OF Carbon Filaments). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2023. By volume, Guangdong sits between Guangdong Fenghua Advanced Technology Holding Co., Ltd. and Guangdong Zhaoqing L&V Co. Ltd..

Guangdong's three-year grant acceleration

Guangdong Newdermo Biotech Co., Ltd shows 6 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Guangdong Fenghua…

6
Guangdong Hua'cha…

6
Guangdong Inspur…

6
Guangdong Midea E…

6
Guangdong Nufront…

6
Guangdong Shengyi…

6
Guangdong SKG Int…

6
Guangdong Zhaoqin…

6
Guangdong Newderm… ◀

6

What this shows Guangdong holds 6 patents at rank #40,453, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Guangdong

By rank, the assignees closest to #40,453 in granted patent volume.

Leaders in D01F (Chemical Features IN THE Manufacture OF Artificial Filaments)

Other assignees with the most granted patents in Guangdong's primary technology class.

Guangdong's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Guangdong Newdermo Biotech Co., Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	5	83.3%
2023	1	16.7%

Which technologies does Guangdong Newdermo Biotech Co., Ltd patent most?

D01F - Chemical Features IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR RIBBONS; Apparatus Specially Adapted FOR THE Manufacture OF Carbon Filaments 1

A46B - Brushes 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

A46D - Manufacture OF Brushes 1

D01D - Mechanical Methods OR Apparatus IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR Ribbons 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Guangdong Newdermo Biotech Co., Ltd's patent record in context - here's where to go next.

Guangdong Newdermo Biotech Co., Ltd's lead technology class is D01F (Chemical Features IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR RIBBONS; Apparatus Specially Adapted FOR THE Manufacture OF Carbon Filaments), 16.7% of its portfolio - see every assignee active in that class. Explore D01F
Ranked #40,555 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Guangdong Newdermo Biotech Co., Ltd against Guangdong Fenghua Advanced Technology Holding Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.